Effect of hydroalcoholic extract of Perovskia abrotanoides on blood glucose and lipid profile by intraperitoneal injection in male diabetic rats

Type 1 diabetes or insulin-dependent diabetes mellitus is due to a lack of insulin secretion caused by the destruction of beta-pancreatic cells. The genus Perovskia-L belongs to the Persian mint family, with pharmacological effects, such as analgesic, anti-inflammatory, treatment of infection, and so on. The aim of the present study was to evaluate the effect of extract of Bromelaceae on blood glucose and biochemical factors in male diabetic rats.

In the experimental study, 60 male Wistar rats weighing 250-200 g were randomly divided into 10 groups of 6 rats each:  control, healthy receiving glibenclamide, healthy treated with 300 ,150 and 600 mg / kg. Body extracts of diabetic rats, diabetic control (hyperglycemia), positive control (hyperglycemia treated with glibenclamide), hyperglycemia treated with 300 ,150, and 600 mg / kg body weight of extract were divided  into two groups. After 14 days of gavage, blood samples were taken from the animals and biochemical factors, such as glucose, insulin, triglyceride, cholesterol, and LDL-cholesterol, were measured. 

The results showed that the hydroalcoholic extract of Bromzebal reduced the mean glucose in the diabetic group from 11 ± 234 to 5± 140 in the treated diabetic groups, the mean cholesterol reduced from 2 ±114 to 5 ±80, and the mean triglyceride from 3 ± 114 to 14 ± 70. Also, LDL reduced from 2± 82 to 5±44. Moreover, hydroalcoholic extract of Bromzebal significantly inhibited increased glucose levels (p<0.001), triglycerides (p<0.001), and cholesterol (p<0.001), and a significant decrease was observed in LDL levels in treated diabetic mice as compared with untreated diabetic animals.

It seems that hydroalcoholic extract of Precambrian has a controlling effect on blood sugar and modulates blood biochemical factors in  diabetic animals and is likely to be effective in
the treatment of diabetes.